A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis

NCT05770609 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Ulcerative Colitis

Interventions

DRUG: SPH3127 Tablets with Dose A
DRUG: SPH3127 Tablets with Dose B
DRUG: SPH3127 Tablets placebo

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd